BP into 2026: why the iron-ore cycle isn't finished yet
Chinese steel intensity is falling, but supply discipline from the majors and grade decline at Vale keep the marginal tonne well bid. Our base case for FY26.
Analysis and views from the Landmark Capital research desk. General advice only — read the disclaimer at the bottom of each article.
Chinese steel intensity is falling, but supply discipline from the majors and grade decline at Vale keep the marginal tonne well bid. Our base case for FY26.
Deposit repricing has run its course, mortgage competition is easing and bad-debt cycles remain benign. The UK majors are cheap on relative multiples again.
Beyond NVIDIA, the winners split between hyperscaler infra, power generation and second-derivative software. Where the earnings revisions are moving.
A four-step checklist we apply to every allocation — from float structure and lock-ups to comparable trading and post-listing float mechanics.
Plasma collection volumes have normalised. The Seqirus flu franchise is the swing factor for FY26 EPS — we walk through the moving parts.
Central-bank buying, negative real rates and de-dollarisation flows have re-rated gold. Position sizing for UK portfolios.
Inventory destock is largely complete; Chinese battery-grade carbonate is finding a floor. Which LSE names have the balance sheets to make it.
Home bias, currency hedging and the case for a permanent US equity sleeve. How we think about drawdowns and rebalancing bands.
Clients receive our full research notes and IPO allocation updates.
Open an account